Kadmon Corporation to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 09/03/15 -- Kadmon Corporation, LLC today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer of Kadmon, will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015 at 12:05 p.m. ET in New York. Dr. Waksal will provide an overview of Kadmon and its clinical and commercial programs.

A live audio webcast of the presentation will be accessible at . The replay will be available for 90 days following the presentation.

Kadmon Corporation, LLC is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in oncology, autoimmune and fibrotic diseases, metabolic disease and certain monogenic diseases. For more information, visit .

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.



Ellen Tremaine
Investor Relations
646.490.2989

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 03.09.2015 - 13:30 Uhr
Sprache: Deutsch
News-ID 417895
Anzahl Zeichen: 4925

contact information:
Town:

NEW YORK, NY

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 319 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at the Rodman & Renshaw 17th Annual Global Investment Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

Kadmon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Kadmon Issues Statement on Rosenfeld Lawsuit ...

NEW YORK, NY -- (Marketwired) -- 06/23/16 -- Kadmon Corporation, LLC today issued the following statement in response to a press release issued on June 22, 2016 from counsel for plaintiff Steven Rosenfeld, regarding the action he commenced on Februa ...

Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Idiopathic Pulmonary ...

NEW YORK, NY -- (Marketwired) -- 06/03/16 -- Kadmon Corporation, LLC today announced that the first patient has been dosed in a Phase 2 clinical trial of KD025, the Company's rho-associated coiled-coil kinase 2 (ROCK2) inhibitor, for the treatm ...

Kadmon to Present Preclinical Data Demonstrating That Its Novel Immuno-Oncology ...

NEW YORK, NY -- (Marketwired) -- 04/14/16 -- Kadmon Corporation, LLC today announced the presentation of new preclinical data demonstrating that its novel anti-PD-L1/IL-15 bi-functional fusion protein, KD033, stimulated long-lasting and persistent a ...

Alle Meldungen von Kadmon Corporation